H29-23583-22529

2 vaccinations 6 coded responses 19 check-ins 6 free-text entries 4 call cases

Sex: Female
Age at first dose: 12-15
ZIP prefix: 841 / UT
Registered: 2021-05-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-20
Dose 1 — Pfizer-BioNTech
2021-05-22
Registered in v-safe
2021-05-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Muscle or body aches

Adult check-in
2021-05-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-05-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache · Be unable to do your normal daily activities

Adult check-in
2021-05-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-27
Health check-in — day 7, dose 1
Feeling: Good · Nausea

Adult check-in
2021-06-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-06-10
Dose 2 — Pfizer-BioNTech
2021-06-11
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-06-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Abdominal pain

Adult check-in
2021-06-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-19
Health check-in — day 7, dose 2
Feeling: Good · Headache

Adult check-in
2021-06-24
Survey response — day 14, dose 2
MedDRA: Hypersensitivity, Migraine, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Worse allergies, increase in migraines (chronic migraine)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-24
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-26
Call 1 — Left Voicemail
2021-07-01
Survey response — day 21, dose 2
MedDRA: Condition aggravated, Migraine, Pre-existing disease — Feeling: Fair

Free text: Worsening symptoms and more frequent attacks associated with chronic migraine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-07-22
Survey response — day 42, dose 2
MedDRA: Hospitalisation, Mental disorder, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Mental health and increase in migraines (chronic) · Healthcare visit (other): Psychiatric inpatient

MedDRA releases: 2024-11 · check-in free text available
2021-07-22
Report sent to call center — day 42, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-26
Call 1 — Left Voicemail
2021-09-11
Survey response — 3 months, dose 2
MedDRA: Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Mental health

MedDRA releases: 2024-11 · check-in free text available
2021-09-11
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-13
Call 1 — Left Voicemail
2021-12-09
Survey response — 6 months, dose 2
MedDRA: Mental disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Mental health

MedDRA releases: 2024-11 · check-in free text available
2021-12-09
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2021-12-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-20	Pfizer-BioNTech
2	2021-06-10	Pfizer-BioNTech

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 2

2021-06-11

Systemic reaction (other): Shortness of breath

Release 9 — day 14, dose 2

2021-06-24

Symptoms: Worse allergies, increase in migraines (chronic migraine)

Release 9 — day 21, dose 2

2021-07-01

Symptoms: Worsening symptoms and more frequent attacks associated with chronic migraine

Release 9 — day 42, dose 2

2021-07-22

Symptoms: Mental health and increase in migraines (chronic)

Healthcare visit (other): Psychiatric inpatient

Release 9 — 3 months, dose 2

2021-09-11

Symptoms: Mental health

Release 10 — 6 months, dose 2

2021-12-09

Symptoms: Mental health

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Hospitalisation	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	Hypersensitivity	✓	✓	✓
SD	Mental disorder	·	·	✓
SD	Migraine	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Unevaluable event	·	·	✓
SRO	Dyspnoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release